Edge SP1000 Single-Port Endoscopic Surgical Robot
Edge Product Family: Edge MP1000 (Multi-Port) | Edge SP1000 (Single-Port) | Edge Bronchoscope (Natural Orifice)
The SP1000 Single-Port Endoscopic Surgical Robot from Edge Medical performs minimally invasive procedures through a single small incision, reducing surgical trauma compared to traditional multi-port approaches. According to Frost & Sullivan, it was the first domestically approved single-port laparoscopic surgical robot in China to cover three or more major surgical specialties.
Product Overview
Edge Medical received NMPA approval for the SP1000 in November 2023 following successful clinical trials in gynecological procedures that began in October 2021. The system entered commercial use in China during 2024 and obtained CE Mark certification in October 2025, enabling European market access.
Single-port robotic surgery offers several theoretical advantages over multi-port approaches: reduced incision count decreases infection risk, shortens anesthesia time, and simplifies surgical procedures while potentially improving cosmetic outcomes. However, the technical complexity of operating multiple instruments through a single access point has historically limited adoption.
Key Features
Approved in November 2023, the SP1000 became the first Chinese single-port robot to cover three or more major surgical specialties through a 25–35 mm incision.
Single-Incision Access: All instruments and the camera enter through one small incision, typically 25-35mm
Compact Design: Lightweight construction requires less operating room space than multi-port systems
Articulated Instruments: Wristed instrument tips provide dexterity within the confined single-port surgical field
Natural Orifice Compatibility: System design accommodates both transcutaneous single-port and natural orifice approaches
Intuitive Control: Master-slave configuration translates surgeon hand movements into precise instrument articulation
Technical Specifications
For single-incision access, the SP1000 passes multiple instruments and a 3D HD camera through one 25–35 mm trocar in a compact, low-footprint design.
| Parameter | Specification |
|---|---|
| Access Type | Single-port (25-35mm incision) |
| Instrument Channels | Multiple through single trocar |
| Visualization | 3D HD endoscopic |
| Footprint | Compact design |
Clinical Applications
The SP1000 is approved for procedures across three primary surgical specialties:
Urology: Robot-assisted radical prostatectomy, partial nephrectomy, radical nephrectomy
Gynecology: Hysterectomy, myomectomy, oophorectomy, sacrocolpopexy
General Surgery: Cholecystectomy, appendectomy, colorectal procedures
Preclinical studies published in peer-reviewed journals demonstrated the SP1000’s feasibility in nephrectomy (porcine model) and transanal total mesorectal excision (taTME). These studies confirmed stable vital signs, absence of significant intraoperative complications, and satisfactory recovery in animal subjects.
By the time of Edge Medical’s IPO, over 2,000 robot-assisted clinical surgeries had been completed using the SP1000 system in China.
Regulatory Status
| Region | Status | Date |
|---|---|---|
| China (NMPA) | Approved | November 2023 |
| European Union (CE) | Approved | October 2025 |
| United States (FDA) | Not Applied | - |
The SP1000 and MSP2000 (integrated single-/multi-port system) received CE Mark certification simultaneously in October 2025, marking the entry of Edge Medical’s single-port technology into international markets.
Competitive Position
The global single-port surgical robot market remains less developed than multi-port systems. Intuitive Surgical’s da Vinci SP is the only FDA-cleared single-port system in the United States. In China, Edge Medical’s SP1000 competes with an emerging group of domestic manufacturers pursuing single-port approvals.
Edge Medical’s advantage lies in its integrated product portfolio—the company can offer hospitals both multi-port (MP1000) and single-port (SP1000) systems, or the combined MSP2000 platform that incorporates both capabilities.
Frequently Asked Questions
What is the difference between SP1000 and MP1000?
The SP1000 performs surgery through a single small incision (typically 25-35mm), while the MP1000 uses multiple ports placed at different locations on the patient’s body. Single-port surgery offers potential benefits in reduced scarring and faster recovery, but multi-port systems provide greater flexibility for complex procedures requiring multiple instrument angles.
Which surgical specialties can use the SP1000?
The SP1000 is approved for urological, gynecological, and general surgical procedures. Common applications include nephrectomy, hysterectomy, and cholecystectomy. According to Frost & Sullivan, it is the first Chinese single-port robot to cover three or more major surgical specialties.
How does SP1000 compare to da Vinci SP?
Both systems enable single-port minimally invasive surgery. The da Vinci SP has broader regulatory clearance (including FDA) and longer commercial history. The SP1000 offers a potentially lower price point and is part of Edge Medical’s integrated platform that can combine single- and multi-port capabilities in a single system (MSP2000).
Browse related categories
Sources
Publicly available references used for the data on this page. See data methodology for verification standards.
